Travere Therapeutics Inc (NASDAQ:TVTX)

25.08
Delayed Data
As of Jul 01
 +0.85 / +3.51%
Today’s Change
12.75
Today|||52-Week Range
31.65
-19.20%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Aselage Stephen J
Director
Buy10/07/202160,000$16.23$973.8K-3.57%
Aselage Stephen J
Director
Sale11/16/202131,800$29.39$934.6K-14.86%
Aselage Stephen J
Director
Sale10/07/202132,000$26.26$840.3K-3.57%
Aselage Stephen J
Director
Sale10/07/202128,000$26.23$734.4K-3.57%
Dube Eric /glaxosmithkline/
Chief Executive Officer
Sale1/05/202210,361$29.84$309.2K-14.34%
Aselage Stephen J
Director
Sale11/05/202110,000$26.23$262.3K-16.64%
Clague Laura M
Chief Financial Officer
Sale1/11/20227,500$27.40$205.5K-9.32%
Dube Eric /glaxosmithkline/
Chief Executive Officer
Sale1/24/20227,873$24.98$196.7K-3.24%
Aselage Stephen J
Director
Buy11/05/202110,000$16.23$162.3K-16.64%
Aselage Stephen J
Director
Sale11/01/20215,000$29.48$147.4K-15.24%
Page of 6